PPCB (Propanc Biopharma) Bathi saben saham sajrone patang kuartal pungkasan

Propanc Biopharma Inc (PPCB) is based on pancreatic enzyme patents and synergy with European and Australian universities. The YoY EPS growth rates over 12 months on this GURU.Markets chart confirm this trajectory, where the 99.70 metric determines this level. The company is currently in the R&D phase, developing proenzymes to combat solid tumor metastases.

PPCB Bathi saben saham sajrone rolas wulan pungkasan Propanc Biopharma (23.11.2025 - 14.11.2026)

Propanc Biopharma, Inc. - rincian analitis lan metrik utama (PPCB)

- rega saiki lan proyeksi nilai saham:

Bagan owah-owahan rega Propanc Biopharma Inc|PPCB - Target konsensus

- indikator valuasi pasar bisnis:

Nilai pasar Propanc Biopharma, Inc.|PPCB - Nilai Perusahaan

- rincian valuasi buku bisnis:

Nilai Buku saben Saham Propanc Biopharma|PPCB - Nilai Buku Perusahaan|Nilai Pasar marang Nilai Buku propanc.com|PPCB - Total Aset Perusahaan

- indikator total utang lan likuiditas perusahaan:

Rasio Utang marang Modal Propanc Biopharma Inc|PPCB - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Propanc Biopharma Inc|PPCB - Gunggung utang perusahaan|Utang marang modal buku Propanc Biopharma, Inc.|PPCB - Utang jangka dawa perusahaan|Utang jangka cendhak Propanc Biopharma|Rasio likuiditas darurat propanc.com

- data bathi lan kelipatan valuasi:

PPCB - Penghasilan resik|Penghasilan resik sing dikarepake Propanc Biopharma Inc|PPCB - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep Propanc Biopharma Inc|PPCB - Pangali PEG|Nilai bisnis marang bathi operasional sadurunge panyusutan Propanc Biopharma, Inc.|PPCB - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Propanc Biopharma|PPCB - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan propanc.com|PPCB - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Propanc Biopharma Inc

- rincian pendapatan lan dodolan:

PPCB - Pendapatan perusahaan|Pendapatan sing dikarepake perusahaan Propanc Biopharma Inc|PPCB - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Propanc Biopharma, Inc.

Pambiji fundamental:Propanc Biopharma (PPCB)

Produk mawa merek Propanc Biopharma Inc.

Propanc Biopharma Inc. reduces risks by diversifying its pipeline for combating solid tumor metastases, yet the actual effectiveness of this strategy is reflected in the growth rate of rolling earnings per share. This indicator measures the speed of business capitalization, neutralizing quarterly reporting gaps to assess the actual growth of shareholder value. Analyzing the year-over-year (12-month) EPS trend allows for the timely identification of trend reversals and the avoidance of losses.

Analisis pesaing Propanc Biopharma Inc